Anemoi International Aktie 57388381 / VGG0419A1057
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
07.10.2025 08:30:05
|
Anemoi International Ltd: ID4 and Zigram Strategic Alliance
|
Anemoi International Ltd (AMOI)
Anemoi International Ltd
Anemoi International Ltd (Reuters: AMOI.L, Bloomberg: AMOI:LN) ("Anemoi" or the "Company") Trading Update
ID4 partners with Zigram to integrate PreScreening.io into its compliance offering, enhancing AML screening excellence for clients worldwide.
The Company is pleased to announce a strategic partnership between ID4 and Zigram, a globally recognized RegTech leader, to integrate PreScreening.io - Zigram’s advanced SaaS solution for PEP, Sanction, and Negative News screening - into our compliance ecosystem and to cooperate commercially across complementary markets.
This collaboration delivers significant benefits for both parties and enhances ID4’s market offering and reach:
Zigram’s integrated services help ID4 clients to:
Commenting, Emmanuel Nay, CEO of id4 stated that “What makes Zigram stand out is their ability to build and maintain their own high-quality data sets for AML screening and risk analysis - something few others in the industry offer.”
“Combined with their expert team of over 430 professionals, Zigram gives id4 and our clients unmatched accuracy, depth, and confidence in compliance processes.”
This partnership reflects ID4’s continued focus on innovation, reliability, and regulatory excellence - empowering our clients with the tools they need to stay ahead in an ever-evolving compliance environment.
Commenting, Duncan Soukup, Chairman stated “The Zigram contract is the first step in id4’s revised strategy to focus on indirect sales through value added resellers. We believe that the relationship with Zigram has the potential to generate significant revenue, which alongside other contracts in early discussion, or others in advanced negotiation has the potential to drive substantial top and bottom line growth for id4 and its Partners.”
The global market size for AML screening services, which includes PEP, sanction screening, and negative news/adverse media screening, is estimated at c. $5 billion in 2025, with projections it will exceed $15 billion by 2033. (Source: https://www.datainsightsmarket.com/reports/aml-screening-1954693)
END
Note to Editors:
About ZIGRAM
ZIGRAM is a global RegTech company specializing in Anti-Money Laundering (AML), Financial Crime Compliance (FCC), and risk management. Its proprietary AML RegTech Stack and Complete AML System enable financial institutions to meet regulatory obligations with simplicity and scale. ZIGRAM’s solutions are cloud-native, self-serve, and designed to address 40+ risk use cases across sectors. With a data library covering 3,200+ watchlists and 250 jurisdictions, ZIGRAM serves clients globally across banking, fintech, insurance, and advisory spaces.
About ID4
ID4 AG is a Swiss RegTech company providing digital solutions for Client Lifecycle Management (CLM) in the financial industry. Its modular SaaS platform helps automate compliance processes, including Anti-Money Laundering (AML), Know Your Customer (KYC), client onboarding, and monitoring, improving efficiency and regulatory alignment. Trusted by wealth managers, financial advisors, pension funds and other regulated institutions, id4 AG supports digital transformation with flexible, client-centric tools recognized for innovation and usability in the RegTech space.
Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. |
| ISIN: | VGG0419A1057 |
| Category Code: | MSCL |
| TIDM: | AMOI |
| LEI Code: | 213800MIKNEVN81JIR76 |
| Sequence No.: | 404276 |
| EQS News ID: | 2208792 |
| End of Announcement | EQS News Service |
|
|
Nachrichten zu Anemoi International Limited Registered Shs
|
28.10.25 |
Anemoi International Ltd: ID4 and Azilen Announce Strategic Partnership (EQS Group) | |
|
27.10.25 |
Anemoi International Ltd: Proposed Acquisition of Trasna Solutions Technologies Limited (EQS Group) | |
|
07.10.25 |
Anemoi International Ltd: ID4 and Zigram Strategic Alliance (EQS Group) | |
|
24.07.25 |
Anemoi International Ltd: Crypto Treasury Management Update (EQS Group) | |
|
07.07.25 |
Anemoi International Ltd: Appointment of Director (EQS Group) | |
|
03.07.25 |
Anemoi International Ltd: Appointment of Director (EQS Group) | |
|
01.07.25 |
Anemoi International Ltd: Crypto Treasury Management Strategy (EQS Group) | |
|
11.06.25 |
Anemoi International Ltd: AGM Results (EQS Group) |
Analysen zu Anemoi International Limited Registered Shs
Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall
Im BX Morning Call spricht die Schweizer Unternehmer-Ikone Etienne Jornod (OM Pharma) mit François Bloch und Olivia Hähnel (BX Swiss) über Führung, Wachstum, Kooperationen, seine Zeit bei der NZZ und darüber, warum Zuhören der wichtigste Leadership-Skill ist.
Die perfekte Folge für alle, die sich für Pharmastrategien, Galenica/Vifor und Unternehmertum interessieren.
🎯 Themen im Interview mit Etienne Jornod (OM Pharma)
– Antrieb und Führungsphilosophie eines Unternehmers
– Erfolgsweg von Galenica – Lehren aus Jahrzehnten Führung
– Frauenquote, Teamkultur und Leadership bei OM Pharma
– Internationale Expansion: China, USA und neue Märkte
– Forschung, Druck und Verantwortung in der Pharmaindustrie
– Inspiration, Balance und persönliche Haltung zum Erfolg
– Zukunftsvisionen: Schweiz, Unternehmertum und Investments
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
SMI leichter erwartet -- DAX vor festerem Start -- Märkte in Fernost mehrheitlich in RotDer heimische Aktienmarkt dürfte am Donnerstag mit Abgaben in den Handel gehen, während sich beim deutschen Börsenbarometer ein kleines Plus abzeichnet. Die wichtigsten asiatischen Börsen weisen überwiegend rote Vorzeichen am Donnerstag aus.


